Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib

By Wang Fenghua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 331-335

Humana Press, Inc

Access to resources Recommend Favorite

Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib

By Kanazawa Shigenori   Yamaguchi Kazuyuki   Kinoshita Yoshimi   Komiyama Yutaka   Muramatsu Mikiko   Nomura Shosaku  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 11, 2006-11 ,pp. : 719-725

Springer Publishing Company

Access to resources Recommend Favorite

Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib

By                              

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 802-806

Science Publishers

Access to resources Recommend Favorite

Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group Experience

By Hotta Katsuyuki   Ueoka Hiroshi   Kiura Katsuyuki   Tabata Masahiro   Ogino Atsuko   Umemura Shigeki   Harita Shingo   Gemba Kenichi   Yonei Toshiro   Bessho Akihiro   Maeda Tadashi   Tanimoto Mitsune  

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 717-722

Informa Healthcare

Access to resources Recommend Favorite